GlassScriptPhysician profile
Sanjeev Kohli
NPI 1164446167
$6,550.33
in general payments reported to CMS, 2019-2025
37 companies · $865 in 2025
The $865 reported for 2025 was more than what 83% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $433 · 2020: $266 · 2021: $897 · 2022: $711 · 2023: $1,057 · 2024: $2,322 · 2025: $865.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,948 · Travel and Lodging: $1,295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,948.38 |
| Travel and Lodging | $1,295.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,656.09 | 2023-2025 | Inspire |
| Harmony Biosciences LLC | $1,091.37 | 2020-2025 | Wakix |
| Abbvie INC. | $473.50 | 2022-2024 | |
| Novo Nordisk INC | $422.55 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $385.98 | 2019-2024 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $329.82 | 2019-2025 | Otezla, Repatha, Evenity |
| Pfizer INC. | $310.47 | 2019-2025 | |
| Vanda Pharmaceuticals INC. | $192.62 | 2020-2023 | Hetlioz |
| Astrazeneca Pharmaceuticals LP | $171.79 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Merck Sharp & Dohme LLC | $170.95 | 2019-2025 | Capvaxive, M-M-R II |
| Glaxosmithkline, LLC. | $163.28 | 2019-2023 | Trelegy Ellipta, Arexvy, Shingrix |
| Phathom Pharmaceuticals, INC. | $127.77 | 2025 | Voquezna |
| Esperion Therapeutics, INC. | $92.09 | 2021-2024 | Nexletol |
| Paratek Pharmaceuticals, INC. | $84.95 | 2021 | |
| Genzyme Corporation | $75.69 | 2019-2020 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjeev Kohli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.